MedPath

Contraceptive Effectiveness Trial of Cellulose Sulfate Gel

Phase 2
Completed
Conditions
Contraception
Registration Number
NCT00255294
Lead Sponsor
CONRAD
Brief Summary

This study will evaluate the contraceptive effectiveness of cellulose sulfate vaginal gel in preventing pregnancy when used for 6 months.

Detailed Description

Cellulose sulfate has been shown in preclinical studies to have both contraceptive and antimicrobial properties. Clinical safety studies have shown it to be safe for use up to six days in women and 7 days in men, and ongoing studies are assessing its safety for twice daily use for 14 days in women. This study will evaluate its contraceptive effectiveness in women who use it for 6 months.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
200
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
1. To estimate the cumulative probability of pregnancy for six months and six cycles of typical use of the CS gel.
2. To estimate the cumulative probability of pregnancy for six cycles of consistent use of the CS gel.
3. To estimate the cumulative probability of study discontinuation through six months of CS gel use.
Secondary Outcome Measures
NameTimeMethod
1. To assess the acceptability of CS gel among female and male users
2. To assess the consistency of use of CS gel among study participants
3. To estimate the frequency of abnormal cytology, candidiasis, urinary tract infections, bacterial vaginosis, and genital irritation during six months of CS gel use.
4. To identify any serious adverse events or patterns of unanticipated adverse events related to the use of CS gel.

Trial Locations

Locations (1)

California Family Health Council

🇺🇸

Los Angeles, California, United States

© Copyright 2025. All Rights Reserved by MedPath